The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 26, No. 7, pp. 910-914.
© 1992 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vial, T
Right arrow Articles by Descotes, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vial, T
Right arrow Articles by Descotes, J

Research Articles

Cefaclor-associated serum sickness-like disease: eight cases and review of the literature

T Vial, J Pont, E Pham, M Rabilloud, and J Descotes

OBJECTIVE: To describe the clinical features of serum sickness-like diseases (SSLD) in cefaclor-treated patients. DESIGN: Analysis of a case series spontaneously reported to Lyons Pharmacovigilance Center. SETTING: General and hospital practitioners and the French Network of Regional Pharmacovigilance Centers (FNRPC). PATIENTS: All reported cases with a possible causative relationship between cefaclor treatment and SSLD. MAIN RESULTS: Eight cases of SSLD following cefaclor treatment are described. The clinical features included cutaneous reactions, arthralgias, and moderate hyperthermia. In 50 percent of the patients, hospitalization was required because of incapacitating symptoms. The outcome was benign in all cases following discontinuation of the offending drug. All eight cases were reported in children under five years of age. Among 137 cefaclor-associated drug reactions collected by FNRPC, 27 cases of SSLD have been reported; 23 of these patients were younger than five years of age. A literature survey confirmed the higher reporting of SSLD in children with cefaclor compared with other antibiotics and suggested an incidence of 0.024-0.2 percent of SSLD per drug course of cefaclor. CONCLUSIONS: The case reports and epidemiologic studies confirmed the presumed role of age (patients under five years of age) in cefaclor-induced SSLD and the benign outcome despite severe clinical presentations in some reports.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
R. L Colton, J. Amir, M. Mimouni, and A. Zeharia
Serum Sickness-Like Reaction Associated with Griseofulvin
Ann. Pharmacother., April 1, 2004; 38(4): 609 - 611.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. Ponvert, L. Le Clainche, J. de Blic, M. Le Bourgeois, P. Scheinmann, and J. Paupe
Allergy to beta -Lactam Antibiotics in Children
Pediatrics, October 1, 1999; 104(4): 45e - 45.
[Abstract] [Full Text]

Home page
 Arch DermatolHome page
P. Mortureux, C. Leaute-Labreze, V. Legrain-Lifermann, T. Lamireau, J. Sarlangue, and A. Taieb
Acute Urticaria in Infancy and Early Childhood: A Prospective Study
Arch Dermatol, March 1, 1998; 134(3): 319 - 323.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1992 by Harvey Whitney Books Company.